Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Second phase I trial to investigate two twice-daily controlled release formulations of DM-1992 (levodopa/carbidopa) compared with a sustained release generic forumation, Sinemet, in patients with Parkinson's disease.

Trial Profile

Second phase I trial to investigate two twice-daily controlled release formulations of DM-1992 (levodopa/carbidopa) compared with a sustained release generic forumation, Sinemet, in patients with Parkinson's disease.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 22 Nov 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 28 Feb 2012 Results published in Clinical Neuropharmacology.
  • 07 Feb 2011 Preliminary results have been reported in a Depomed media release. Further results are expected to be presented at an upcoming conference in 2011.
  • 07 Feb 2011 Status changed from planning to completed.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top